Partners Innovation Fund LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Partners Innovation Fund LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10573
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Partners Innovation Fund LLC (PIF), a subsidiary of Partners HealthCare System Inc focuses to invest in healthcare companies based on intellectual property created within its research community. The company provides capital to seed and early stage medical devices, diagnostics, digital health and drug development companies. PIF specializes in offering finance and support to its portfolio companies through their complete financing lifecycles. The company’s portfolio companies include Abcuro Inc, Life Image Inc, Tilos Therapeutics Inc, Sebacia Inc, SwanBio Therapeutics Ltd, and Syntimmune Inc among others. PIF is headquartered in Cambridge, Massachusetts, the US.

Partners Innovation Fund LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Akouos Raises USD50 Million in Series A Financing 12
SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14
Akouos Raises USD7.5 Million in Seed Financing 15
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics Raises USD30 Million in Series B Funding 21
Editas Medicine Raises USD120 Million in Series B Financing 23
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28
Quartet Medicine Raises USD17 Million in Series A Venture Financing 30
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 33
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35
Editas Medicine Raises US$43 Million In Series A Financing 36
Annovation BioPharma Raises US$8 Million In Series A Financing 38
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 39
Acquisition 41
Novartis Acquires CoStim Pharma 41
Partners Innovation Fund LLC – Key Competitors 43
Partners Innovation Fund LLC – Key Employees 44
Partners Innovation Fund LLC – Locations And Subsidiaries 45
Head Office 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Key Facts 2
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Partners Innovation Fund LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Akouos Raises USD50 Million in Series A Financing 12
SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14
Akouos Raises USD7.5 Million in Seed Financing 15
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics Raises USD30 Million in Series B Funding 21
Editas Medicine Raises USD120 Million in Series B Financing 23
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28
Quartet Medicine Raises USD17 Million in Series A Venture Financing 30
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 33
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35
Editas Medicine Raises US$43 Million In Series A Financing 36
Annovation BioPharma Raises US$8 Million In Series A Financing 38
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 39
Novartis Acquires CoStim Pharma 41
Partners Innovation Fund LLC, Key Competitors 43
Partners Innovation Fund LLC, Key Employees 44

List of Figures
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Partners Innovation Fund LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Eisai Co Ltd (4523):企業の財務・戦略的SWOT分析
    Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Medica Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medica Corp (Medica) is a medical device company that manufactures and markets in-vitro diagnostic blood testing analyzers. The company’s products comprise clinical chemistry analyzers, electrolyte analyzers, blood gas analyzers, and hematology analyzers, and OEM ISE modules. Medica’s produc …
  • Maxim Power Corp.:企業の発電所・SWOT分析2018
    Maxim Power Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Onxeo SA (ONXEO):製薬・医療:M&Aディール及び事業提携情報
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Korea Aerospace Industries Ltd:企業の戦略・SWOT・財務分析
    Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT Hexindo Adiperkasa Tbk:企業の戦略・SWOT・財務分析
    PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析
    Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • YRC Worldwide Inc.:企業の戦略・SWOT・財務情報
    YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report Summary YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Ultra Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Ultra Petroleum Corp (Ultra) is an independent upstream company, which develops, produces, operates, explores, and acquires oil and natural gas properties. It develops long-life natural gas rese …
  • BASF SE:戦略・SWOT・企業財務分析
    BASF SE - Strategy, SWOT and Corporate Finance Report Summary BASF SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Charles River Laboratories International, Inc.:企業のM&A・事業提携・投資動向
    Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • Platte River Power Authority:企業の発電所・SWOT分析2018
    Platte River Power Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Saudi Kayan Petrochemical Co (2350):企業の財務・戦略的SWOT分析
    Saudi Kayan Petrochemical Co (2350) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • United Bank Of India
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • FlightSafety International Inc:企業の戦略・SWOT・財務情報
    FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report Summary FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報
    Summary Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆